Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade

08 April 2021 - 17:30

Company release

Nanoform Finland Plc

April 8, 2021

06.30 p.m. Finnish time / 05.30 p.m. Swedish time


Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade

Manager’s transaction related to Nanoform Finland Plc’s other senior manager Gonçalo Andrade’s share subscription with stock options from option program 2/2019.


Person subject to the notification requirement

Name: Gonçalo Andrade

Position: Other senior manager

Issuer: Nanoform Finland Plc

LEI: 743700JJO2NU8LBS1592


Reference number: 743700JJO2NU8LBS1592_20210408145838_2


Transaction date: 2021-04-06

Venue not applicable

Instrument type: SHARE

ISIN: FI4000330972

Nature of the transaction: EXERCISE OF A STOCK OPTION

(X) Linked to stock option program

Transaction details

(1): Volume: 25,000 Unit price: 1.1 EUR

Aggregated transactions

(1): Volume: 25,000 Volume weighted average price: 1.1 EUR


For further information, please contact:

Peter Hänninen, General Counsel

[email protected] / +358 50 353 0408

For investor relations queries, please contact:

Henri von Haartman, Director of Investor Relations

[email protected] / +46 7686 650 11


About Nanoform

Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 562 1806. For more information please visit

Provided by: Cision
Nasdaq First North GM (Sweden)
Nanoform Finland Oyj
Nanoform Finland PLC is an nanoparticle medicine enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nanoforming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nanoformed API particles as small as 10nm. Thi...
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More